Journal article
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study
Abstract
IntroductionThe clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148), we described and compared cohorts of adult patients with CKD and T2D initiating a sodium-glucose cotransporter 2 inhibitor (SGLT2i) before the launch of finerenone in Europe, Japan, and the United States (US).MethodsThis was a multinational, …
Authors
Johannes CB; Ziemiecki R; Pladevall-Vila M; Ebert N; Kovesdy CP; Thomsen RW; Baak BN; García-Sempere A; Kanegae H; Coleman CI
Journal
Diabetes Therapy, Vol. 16, No. 2, pp. 205–226
Publisher
Springer Nature
Publication Date
February 2025
DOI
10.1007/s13300-024-01671-x
ISSN
1869-6953